Endotoxemia is associated with better clinical outcome in incident chinese peritoneal dialysis patients: A prospective cohort study

Peritoneal Dialysis International

Volumn 30, Issue 2, 2010, Pages 178-186

  Szeto, Cheuk Chun ^a   Kwan, Bonnie Ching Ha ^a   Chow, Kai Ming ^a   Lai, Ka Bik ^a   Pang, Wing Fai ^a   Chung, Kwok Yi ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiovascular disease; Renal failure; Survival

Indexed keywords

LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; BLOOD LEVEL; CARBOHYDRATE ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTOXEMIA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT FAILURE;

CHINA; COHORT STUDIES; ENDOTOXEMIA; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77957608933     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2008.00242     Document Type: Article

References (48)

1. Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006; 48:392-401.
2. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 2003; 16:101-5.
3. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 2003; 18:977-82.
4. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16:489-95.
5. Szeto CC, Chow KM, Woo KS, Chook P, Kwan BC, Leung CB, et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese pre-dialysis chronic kidney diseases patients. J Am Soc Nephrol 2007; 18:1966-72.
6. Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 2006; 166:1884-91.
7. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154-2169.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-26.
9. Stenvinkel P. Inflammation in end-stage renal failure: could it be treated? Nephrol Dial Transplant 2002; 17(Suppl 8):S33-8.
10. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-911.
11. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54:627-36.
12. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 1997; 30:923-7.
13. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001; 103:1064-70.
14. Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 1999; 34:1975-81.
15. Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:2227-36.
16. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71.
17. Wiedermann CJ, Kiechl S, Schratzberger P, Dunzendorfer S, Weiss G, Willeit J. The role of immune activation in endotoxin-induced atherogenesis. J Endotoxin Res 2001; 7:322-6.
18. Mayr FB, Spiel AO, Leitner JM, Firbas C, Sieghart W, Jilma B. Effects of low dose endotoxaemia on endothelial progenitor cells in humans. Atherosclerosis 2007; 195:e202-6.
19. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007.
20. de Almeida Duarte JB, de Aguilar-Nascimento JE, Nascimento M, Nochi RJ Jr. Bacterial translocation in experimental uremia. Urol Res 2004; 32:266-70.
21. Selgas R, Bajo MA, Jimenez C, Sanchez C, Del Peso G, Cacho G, et al. Peritoneal dialysis in liver disorders. Perit Dial Int 1996; 16(Suppl 1):S215-19.
22. Szeto CC, Kwan BC, Chow KM, Lai KB, Chung KY, Leung CB, et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 2008; 3:431-6.
23. Beddhu S, Zeidel ML, Saul M, Seddon P, Samore MH, Stoddard GJ, et al. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 2002; 112:696-701.
24. Twardowski ZJ, Nolph KD, Prowant B, Ryan L, Moore H, Nielsen MP. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
25. Szeto CC, Chow KM, Lam CW, Leung CB, Kwan BC, Chung KY, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation-products-a one-year randomized control trial. Nephrol Dial Transplant 2007; 22:552-9.
26. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Strackee J, Arisz L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif 1986; 4:194-203.
27. Noe DA. A body surface area nomogram based on the formula of Gehan and George. J Pharm Sci 1991; 80:501-2.
28. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients-a randomized placebo-control trial. J Am Soc Nephrol 2003; 14:2119-26.
29. Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 1998; 18:467-73.
30. Cox D. Regression models and life-tables. Journal of the Royal Statistical Society 1972; 34:187-201.
31. Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58: 400-7.
32. Szeto CC, Law MC, Wong TY, Leung CB, Li PK. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients-a two-year prospective study. Am J Kidney Dis 2001; 37:329-36.
33. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet 2000; 356:930-3.
34. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57:1470-81.
35. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008; 87: 1219-23.
36. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761-72.
37. Enia G, Sicus C, Alati G, Zoccali C. Subjective Global Assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993; 8:1094-8.
38. Chan JY, Che KI, Lam KM, Chow KM, Chung KY, Li PK, et al. Comprehensive malnutrition inflammation score as a marker of nutritional status in Chinese peritoneal dialysis patients. Nephrology (Carlton) 2007; 12:130-4.
39. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverseepidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43:1439-44.
40. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
41. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis 2001; 38(4 Suppl 1):S4-7.
42. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353:1838-42.
43. Szeto CC, Chow KM, Leung CB, Wong TY, Wu AK, Wang AY, et al. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney Int 2001; 59:2309-15.
44. Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 2006; 69:1245-52.
45. Nisbeth U, Hällgren R, Eriksson O, Danielson BG. Endotoxemia in chronic renal failure. Nephron 1987; 45:93-7.
46. Magnusson M, Magnusson KE, Sundqvist T, Denneberg T. Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut 1991; 32:754-9.
47. Magnusson M, Magnusson KE, Denneberg T. Impaired gut barrier in experimental chronic uremic rats. Miner Electrolyte Metab 1992; 18:288-92.
48. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007; 50:1561-9.